| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |